weight regulation hormones Flashcards


Set Details Share
created 1 year ago by Rereih
2 views
show moreless
Page to share:
Embed this setcancel
COPY
code changes based on your size selection
Size:
X
Show:

1

what is the base of the development of weight-reduction therapeutic agents?

Targeting the complex peripheral and central signals involved in weight regulation

2

Cholecystokinin (CCK) secretion responsible organs

  • duodenum
  • jejunum

3

cck receptors

cck a

cck b

4

CCK levels

plasma levels rise within 15 min

5

cck physiology or effects

  1. reduce food intake and in response to meal initiation
  2. local regulatory
  3. stimulation of gallbladder contraction
  4. inhibition of gastric emptying

6

cck drug effects

  • reduce food intake (meal size and duration)
  • increases in meal frequency
  • development of tolerance
  • short half-life of the peptide
  • hold minimal promise as a future antiobesity tool

7

ghrelin secretion organs

stomach

8

ghrelin receptors

  • Binds to the growth hormone secretagogue receptor (GHSR)
  • in the hypothalamus and brain stem
  • Signaling mechanisms (ARC) and (NPY)/ (AgRP)
    expressing neurons

9

ghrelin levels

  • Obese >fasting ghrelin levels lower following diet-induced weight loss
  • obese > post-prandial fall in circulating ghrelin levels

10

ghrelin sc injection effects

  • induce appetite
  • increase food intake

11

ghrelin drugs

  • pre-prandial receptor blockade
  • NPY and AgRP antagonists

12

pp secretion organs

  • endocrine pancreas
  • colon
  • rectum

13

pp receptors

  • hypothalamic arcute nucleus (ARC) > Y4 receptors
  • increase endogenous PP production
  • avoiding degradation in the circulation,
  • increase Y4-mediated signaling

14

pp levels

  • low > during the fasting
  • rise > in proportion to caloric intake

15

pp drug effects

  • reduction in appetite
  • reduction food intake

16

pyy secretion organs

L-cells of the GI tract

17

pyy receptor

  • Y family of G protein-coupled receptor
  • preferentiality for the Y2 receptor

18

pyy levels

  • influenced by meal composition and calorie content
  • elevated within 1 h post-feeding
  • often lower in the obese state

19

ppy drug

  • Inhibition of food intake > selective Y2 agonist
  • attenuation of this inhibitory effect > Y2 antagonists
  • IV PYY3-36 > decrease in appetite and 30% restriction in caloric intake

20

GLP-1 secretion organ

small intestinal and colonic L-cells

21

GLP 1 receptor

GLP 1 R

22

GLP 1 levels in obese patients

  • delays in the post-prandial release
  • reduced circulating levels of the peptide

23

GLP 1 drug

  • anorexigenic effects
  • influences on food intake
  • reduction in gastric emptying
  • suppression of gastric acid secretion
  • GLP-1 or GLP-1 receptor agonists > satiety, reduce food intake, weight loss

24

GLP 1 limitation to its possible therapeutic utility

  • inactivation and clearance by (DPP-IV)
  • short half-life of GLP-1 > 5 min

25

Oxyntomodulin (OXM) secretion organ

intestinal L cells

26

OXM receptor

GLP 1 R

27

OXM drug

  • increases satiation and reduces food intake
  • decreases in body weight
  • increased energy expenditure

28

leptin secretion

white adipose tissue adipocytes

29

leptin levels in obesity

  • proportional to fat mass
  • increased circulating leptin levels
  • lack of leptinmediated effects
  • leptin resistance > Receptor overstimulation > negative feedback loops > block leptin signaling

30

leptin effects

  • inhibit the orexigenic NPY/AgRP
  • stimulate the anorexigenic POMC
  • within the hypothalamic arcuate nucleus

31

leptin drug effects

  • reduce food intake
  • reduce body weight
  • increase energy expenditure

32

leptin vs insulin

  • central effects on food intake and energy homeostasis are less efficient
  • insulin > stimulate the synthesis and secretion of
    leptin > through a feedback loop (adipoinsular axis)
  • Common hypothalamic targets
  • crosstalk between the two hormones

33

insulin levels

  • proportional to the degree of adiposity

34

Integration of Satiation and Adiposity Signals

  • meals are initiated > non-homeostatic influences
  • meal termination > satiation signals
  • The efficacy of satiation signals varies with the amount of fat in the body as signaled to the brain by leptin and insulin

35

Integration of Satiation and Adiposity Signals - food restricted & loses weight

  1. leptin and insulin secretion both decline
  2. reduced adiposity signal reaches the arcuate nucleus
  3. lowers sensitivity to satiation signals
  4. more food is eaten during meals before satiation

36

Integration of Satiation and Adiposity Signals - Individuals who have overeaten and gained weight

  1. have elevated levels of adiposity signals
  2. enhanced sensitivity to satiation signals
  3. reducing the trajectory of weight gain or even promoting weight loss
  4. low doses of leptin or insulin are infused directly into the brain near the arcuate nucleus
  5. enhance satiation signals to reduce food intake